Pharmaron Beijing Co Ltd (300759) — Net Asset Quality Index
Pharmaron Beijing Co Ltd (300759) has a Net Asset Quality Index of 58.8% as of September 2025. This metric measures the proportion of total assets financed by shareholders' equity — total assets of CN¥25.80 Billion minus total liabilities of CN¥10.62 Billion yields net assets of CN¥15.18 Billion. A higher index indicates a stronger, lower-leverage balance sheet. See Pharmaron Beijing Co Ltd (300759) defensive interval to measure how many days the company can operate on defensive assets alone.
Quality Index
Net Assets
Total Assets
Total Liabilities
Pharmaron Beijing Co Ltd Net Asset Quality Index Over Time (2014–2024)
This chart shows how Pharmaron Beijing Co Ltd's Net Asset Quality Index has evolved across 11 annual periods from 2014 to 2024. As of September 2025, the index stands at 58.8%, representing net assets of CN¥15.18 Billion against total assets of CN¥25.80 Billion CNY. Explore Pharmaron Beijing Co Ltd (300759) cash flow conversion to assess how effectively this company generates cash.
Annual Net Asset Quality Index for Pharmaron Beijing Co Ltd (2014–2024)
The table below presents the year-by-year Net Asset Quality Index for Pharmaron Beijing Co Ltd from 2014 to 2024, covering 11 annual filings. Each row shows total assets, total liabilities, net assets, the quality index percentage, and the change in percentage points compared to the prior year. For market capitalisation and the full company profile, see 300759 company net worth.
| Year | Quality Index | Net Assets (CNY) | Total Assets | Total Liabilities | Change (pp) |
|---|---|---|---|---|---|
| 2024 | 59.4% | CN¥14.22 Billion | CN¥23.93 Billion | CN¥9.70 Billion | ▲ +9.4 pp |
| 2023 | 50.0% | CN¥13.24 Billion | CN¥26.48 Billion | CN¥13.24 Billion | ▼ -2.9 pp |
| 2022 | 52.9% | CN¥10.84 Billion | CN¥20.49 Billion | CN¥9.65 Billion | ▼ -3.1 pp |
| 2021 | 56.0% | CN¥10.30 Billion | CN¥18.39 Billion | CN¥8.09 Billion | ▼ -19.0 pp |
| 2020 | 75.0% | CN¥8.93 Billion | CN¥11.91 Billion | CN¥2.98 Billion | ▼ -3.9 pp |
| 2019 | 78.9% | CN¥7.84 Billion | CN¥9.94 Billion | CN¥2.10 Billion | ▲ +28.3 pp |
| 2018 | 50.6% | CN¥2.34 Billion | CN¥4.63 Billion | CN¥2.28 Billion | ▼ -0.7 pp |
| 2017 | 51.3% | CN¥2.01 Billion | CN¥3.92 Billion | CN¥1.91 Billion | ▼ -11.6 pp |
| 2016 | 62.9% | CN¥1.76 Billion | CN¥2.80 Billion | CN¥1.04 Billion | ▲ +48.5 pp |
| 2015 | 14.3% | CN¥168.43 Million | CN¥1.17 Billion | CN¥1.01 Billion | ▼ -13.4 pp |
| 2014 | 27.7% | CN¥258.25 Million | CN¥931.46 Million | CN¥673.22 Million | — |